ARCaDia: single-round screening of a DNA-type targeted covalent binder possessing a latent warhead
Open Access
- 8 November 2024
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (100) , 14964-14967
Abstract
A covalent binder was identified using a single-round screening from a latent-warhead-modified DNA library, coupled with top k-mer analysis to pinpoint the optimal warhead position on the aptamer.Keywords
Funding Information
- JKA Foundation
- Japan Society for the Promotion of Science (#21K05287, 21K12123, 20K20533)
This publication has 25 references indexed in Scilit:
- Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An UpdateJournal of Medicinal Chemistry, 2024
- The expanding repertoire of covalent warheads for drug discoveryDrug Discovery Today, 2023
- Recent progress in covalent warheads for in vivo targeting of endogenous proteinsBioorganic & Medicinal Chemistry, 2021
- Protein Labeling and Crosslinking by Covalent AptamersAngewandte Chemie International Edition, 2021
- G-quadruplex-based aptamers targeting human thrombin: Discovery, chemical modifications and antithrombotic effectsPharmacology & Therapeutics, 2021
- Developing Covalent Protein Drugs via Proximity-Enabled Reactive TherapeuticsCell, 2020
- Combinatorially Screened Peptide as Targeted Covalent Binder: Alteration of Bait-Conjugated Peptide to Reactive ModifierBioconjugate Chemistry, 2018
- Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapiesDrug Discovery Today, 2015
- Highly Potent Irreversible Inhibitors of Neutrophil Elastase Generated by Selection from a Randomized DNA−Valine Phosphonate LibraryBiochemistry, 1997
- In vitro selection of RNA-based irreversible inhibitors of human neutrophil elastaseChemistry & Biology, 1995